Fox Run Management L.L.C. Purchases Shares of 26,449 Avantor, Inc. (NYSE:AVTR)

Fox Run Management L.L.C. acquired a new position in Avantor, Inc. (NYSE:AVTR) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 26,449 shares of the company’s stock, valued at approximately $557,000.

Several other large investors have also modified their holdings of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock valued at $26,000 after acquiring an additional 625 shares during the period. Smartleaf Asset Management LLC lifted its position in shares of Avantor by 106.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares during the last quarter. Global Retirement Partners LLC boosted its stake in Avantor by 76.7% during the 4th quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock valued at $52,000 after purchasing an additional 1,067 shares during the period. UMB Bank n.a. grew its holdings in Avantor by 56.3% in the 4th quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock valued at $63,000 after buying an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC bought a new position in Avantor in the 4th quarter worth approximately $65,000. 95.08% of the stock is owned by institutional investors.

Insider Transactions at Avantor

In related news, CAO Steven W. Eck sold 4,907 shares of Avantor stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now directly owns 40,604 shares of the company’s stock, valued at $711,788.12. The trade was a 10.78 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now directly owns 87,379 shares in the company, valued at approximately $1,531,753.87. This represents a 4.12 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by company insiders.

Avantor Stock Performance

Avantor stock opened at $16.53 on Tuesday. The firm has a market capitalization of $11.25 billion, a P/E ratio of 15.89, a P/E/G ratio of 1.55 and a beta of 1.30. The stock has a fifty day moving average price of $18.87 and a two-hundred day moving average price of $21.63. Avantor, Inc. has a 52-week low of $15.37 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last announced its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a net margin of 10.49% and a return on equity of 12.17%. During the same quarter in the prior year, the company posted $0.22 earnings per share. As a group, analysts anticipate that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on AVTR shares. Morgan Stanley lowered their price objective on shares of Avantor from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Stifel Nicolaus dropped their price objective on shares of Avantor from $28.00 to $26.00 and set a “buy” rating on the stock in a report on Monday, February 10th. Barclays reduced their target price on shares of Avantor from $26.00 to $23.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Raymond James restated an “outperform” rating and set a $24.00 price target (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Finally, UBS Group reiterated a “neutral” rating and issued a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $25.50.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.